Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingFeb 12, 2025Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0216-2025Class IIOngoingFeb 12, 2025Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.Glenmark Pharmaceuticals Inc., USA · D-0215-2025Class IIOngoingFeb 12, 2025Timolol Maleate Ophthalmic Solution USPDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.FDC Limited · D-0214-2025Class IIOngoingFeb 5, 2025InflectracGMP Deviations: Product intended for quarantine was inadvertently distributed.McKesson · D-0213-2025Class IITerminatedFeb 5, 2025Duloxetine Delayed-Release Capsules USPCGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limitThe Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · D-0212-2025Class IOngoingFeb 5, 2025PrografFailed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsulesAstellas Pharma US Inc. · D-0211-2025Class IOngoingFeb 5, 2025Astagraf XLFailed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsulesAstellas Pharma US Inc. · D-0210-2025Class IIITerminatedFeb 5, 2025BADGER 50Labeling: Missing Label: The finished product potentially missing the labeling with the drug facts panel, bar code and directions for use.The W.S. Badger Company, Inc. · D-0209-2025Class IIICompletedJan 29, 2025Venlafaxine Extended-Release TabletsFailed Tablet/Capsule Specifications: Missing tab ID on either side of the tabletAppco Pharma LLC · D-0208-2025Class IOngoingJan 29, 2025FOUZEE SugarLin HERBAL FORMULA capsulesMarketed without an Approved NDA/ANDA; FDA laboratory analysis confirmed product tainted with undeclared metformin and glyburideShoppers- Plaza · D-0207-2025Class IIOngoingJan 29, 2025First Aid Beauty Ultra Repair CreamCGMP Deviations; product intended for quarantine was inadvertently distributedFirst Aid Beauty Ltd · D-0206-2025Class IIOngoingJan 29, 2025Kissable Diabetics Foot CreamCGMP Deviations: lack of adequate release testing.Brands International Corporation · D-0205-2025Class IITerminatedJan 22, 2025Cardura XLFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.Viatris Inc · D-0204-2025Class IITerminatedJan 22, 2025Cardura XLFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.Viatris Inc · D-0203-2025Class IITerminatedJan 22, 2025glipiZIDEFailed Dissolution Specifications:Amerisource Health Services LLC · D-0202-2025Class IIOngoingJan 22, 2025Clobazam TabletsPresence of Foreign Tablets/CapsulesAmerisource Health Services LLC · D-0201-2025Class IOngoingJan 22, 2025Systane Lubricant Eye DropsNon-SterilityAlcon Research LLC · D-0200-2025Class IIIOngoingJan 22, 2025Diphenhydramine HCl 50 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0199-2025Class IIIOngoingJan 22, 2025Diphenhydramine HCl 25 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0198-2025Class IIIOngoingJan 22, 2025Diphenhydramine HCl 25 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0197-2025Class IIIOngoingJan 22, 2025Acetaminophen Extra Strength 500 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0196-2025Class IIIOngoingJan 22, 2025AcetaminophenLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0195-2025Class IIIOngoingJan 22, 2025Acetaminophen Regular StrengthLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0194-2025Class IIIOngoingJan 22, 2025Acetaminophen Extra Strength 500 mgLabeling: Not Elsewhere Classified: Tablets/Capsules imprinted with wrong ID.Akron Pharma, Inc. · D-0193-2025Class IITerminatedJan 15, 2025Metformin Hydrochloride Extended-Release TabletsPresence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.Granules Pharmaceuticals Inc. · D-0192-2025Class IIOngoingJan 15, 2025Kit for the Preparation of Technetium Tc 99m Sulfur Colloid InjectionFailed Stability SpecificationsJubilant Draximage Inc., dba Jubilant Radiopharma · D-0191-2025Class IIOngoingJan 15, 2025Duloxetine DR Capsules USP 60 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0190-2025Class IIOngoingJan 15, 2025Duloxetine Delayed-Release Capsules USP 20 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0189-2025Class IIOngoingJan 15, 2025Duloxetine Delayed-Release Capsules USP 30 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.Rising Pharma Holding, Inc. · D-0188-2025Class IITerminatedJan 15, 2025Colchicine Capsules 0.6 mgFailed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.Granules Pharmaceuticals Inc. · D-0187-2025Class IIOngoingJan 15, 2025Progesterone Injection USPPresence of Particulate Matter: A market complaint was received of a glass piece in the vial.Eugia US LLC · D-0186-2025Class IIOngoingJan 15, 2025medroxyPROGESTERone Acetate Injectable SuspensionCGMP DeviationsEugia US LLC · D-0185-2025Class IIOngoingJan 15, 2025Clobazam TabletsPresence of Foreign Tablets/CapsulesAmerisource Health Services LLC · D-0184-2025Class IIIOngoingJan 15, 2025Methadone Hydrochloride TabletsFailed Tablet/Capsule Specifications: Illegible product identification for the unit dose configuration only.West-Ward Columbus Inc · D-0183-2025Class IIOngoingJan 15, 2025Ciprofloxacin Ophthalmic Solution USPDefective container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottleFDC Limited · D-0182-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0181-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0180-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletsLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0179-2025Class IOngoingJan 15, 2025Clonazepam Orally Disintegrating TabletLabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.Endo USA, Inc. · D-0178-2025Class IOngoingJan 15, 2025Nhan Sam Tuyet Lien Truy Phong HoanMarketed without an Approved NDA/ANDA: FDA analysis found the products to be tainted with undeclared Furosemide, Dexamethasone and ChlorpheniramineBuy-Herbal · D-0177-2025

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.